Sweets maker Imuraya Group Co. sold a record 290 million units of its Azuki Bar ice lolly series to help push its sales to 42.1 billion yen and increase its net profit by 4.7 times from last year to 650 million yen in the fiscal year ending in March 2021.
The stay-at-home trend due to the pandemic buoyed the company's sales of ice lollies.
The Tsu, Mie Prefecture-based firm also sells "yokan” jelly, “shiruko” soup, frozen meat buns, and a new bun product of soybeans instead of pork that have proved popular.
Price drops also helped boost Imuraya’s profits.
However, Imuraya's sales of “nikuman” or buns filled with meat and “anman” or bean paste-filled buns were sluggish.
Imuraya is looking to post sales of 41 billion yen and an 820 million yen net profit in fiscal 2021 ending in March 2022.
Based on its 3-wear midterm management plan through fiscal 2023, Imuraya anticipates sales of 46.5 billion yen and an increase in its overseas business ratio to 7.5 percent from 5.4 percent in fiscal 2020.
Imuraya is seeking to bolster sales of frozen sweets in Southeast Asia, primarily in Malaysia, where it has an affiliate corporation.


Australian Household Spending Dips in December as RBA Tightens Policy
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains
Washington Post Publisher Will Lewis Steps Down After Layoffs
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target
Gold and Silver Prices Rebound After Volatile Week Triggered by Fed Nomination
Anta Sports Expands Global Footprint With Strategic Puma Stake
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
RBI Holds Repo Rate at 5.25% as India’s Growth Outlook Strengthens After U.S. Trade Deal 



